Resources for Hospitals
These practical tools and informational resources are designed to help hospitals and health systems launch, optimize, and protect regulated device reprocessing programs.
Whether you work in procurement (including for a GPO), clinical care, sustainability, or the C-suite, you’ll find guidance here to reduce costs, waste and emissions, strengthen your supply chain, and defend your facility’s right to choose reprocessed devices—even in the face of interference from some original equipment manufacturers.
Practical Tools
AMDR’s Action Alerts and Technical Tips provide awareness and guidance on important industry developments that could impact your facility’s ability to deliver affordable, sustainable healthcare. Each Alert and Tip breaks down complex legal, regulatory, or market issues into clear guidance for hospital leadership, supply chain and procurement staff, and commercial reprocessors.
Whether it’s about anti-competitive behavior or a critical regulatory shift, you’ll find what’s at stake—and what to do next—right here.
Hospitals that reprocess can achieve staggering reductions in costs, waste, and emissions—but many miss out on the full benefits. To make the most of reprocessing, hospitals need to know how to build or scale it, measure impact, engage staff, and make reprocessing a pillar of their facility.
Read our “best practices” guide for practical steps to optimize your reprocessing program.
AMDR’s hospital SUD reprocessing policy template (click here to download) helps health systems formalize their commitment to reprocessing, resist OEM interference, and embed fair contracting standards into procurement.
Protect your hospital’s right to reprocess—with a procurement policy built for the purpose. Includes customizable language, enforcement mechanisms, and legal precedent.
Hospitals rely on reprocessed devices to cut costs, reduce waste, and strengthen supply chains, but some OEMs undermine these goals through anti-reprocessing practices. But hospitals have the power to protect their freedom of choice in purchasing—through strong procurement policies.
AMDR’s Procurement Checklist to Preempt OEM Anti-Reprocessing Efforts helps procurement leaders in health systems and GPOs protect cost-saving reprocessing programs by embedding best practices and legal precedent in their procurement contracts and agreements.
AMDR’s free CO₂ calculator estimates emissions reductions using peer-reviewed life cycle assessments of reprocessed vs. original SUDs. Hospitals can reduce Scope 3 emissions by up to 65% with reprocessed devices—stats like that help earn certification from the Joint Commission.
Try our calculator to see just how much you can help the climate by using reprocessed devices.
Informational Resources
Some device manufacturers interfere with regulated reprocessing, despite the benefits it brings to healthcare. At least one U.S. court has found that such interference can be illegal, and research has shown it to be a major barrier to the success of reprocessing programs.
This page explains how to recognize and report anti-reprocessing tactics and protect your right to choose regulated reprocessed devices.
Innovative Health, LLC v. Biosense Webster, Inc. is a watershed moment in the device reprocessing, healthcare, and medtech industries. The trial exposed the anticompetitive practices that Biosense Webster used to undermine AMDR-member, regulated reprocessing companies – and how these practices inflated healthcare costs, undermined hospital choice, and risked compromising device quality.
Visit our case webpage for more information about what happened – and what it means for healthcare.
Decades of scientific research, government oversight, and routine clinical use around the world have consistently demonstrated that, under strong regulatory frameworks, reprocessed “single-use” devices are safe.
This page explains how rigorous regulation and industry integrity ensure the safety and quality of reprocessed devices—and how they can reduce broader harms such as greenhouse gas emissions, costs, pollution, and supply-chain vulnerabilities.
Modern medical devices come from all over the world. They rely on fragile global supply chains and scarce materials, making healthcare vulnerable to disruptions—a reality made painfully visible during the COVID-19 pandemic.
This page explains why regulated reprocessing is a key strategy for resilient, sustainable healthcare supply chains. By extending the life of our devices and keeping them out of the waste stream for longer, reprocessing conserves critical resources and protects patient access during crises.
